CVE-2026-21970

{"dataType": "CVE_RECORD", "dataVersion": "5.2", "cveMetadata": {"cveId": "CVE-2026-21970", "assignerOrgId": "43595867-4340-4103-b7a2-9a5208d29a85", "state": "PUBLISHED", "assignerShortName": "oracle", "dateReserved": "2026-01-05T18:07:34.715Z", "datePublished": "2026-01-20T21:56:35.163Z", "dateUpdated": "2026-01-21T18:59:51.402Z"}, "containers": {"cna": {"providerMetadata": {"orgId": "43595867-4340-4103-b7a2-9a5208d29a85", "shortName": "oracle", "dateUpdated": "2026-01-20T21:56:35.163Z"}, "problemTypes": [{"descriptions": [{"lang": "en-US", "description": "Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data."}]}], "affected": [{"vendor": "Oracle Corporation", "product": "Oracle Life Sciences Central Designer", "versions": [{"version": "7.0.1.0", "status": "affected", "versionType": "semver"}]}], "cpeApplicability": [{"nodes": [{"operator": "OR", "negate": false, "cpeMatch": [{"vulnerable": true, "criteria": "cpe:2.3:a:oracle:life_sciences_central_designer:7.0.1.0:*:*:*:*:*:*:*"}]}]}], "descriptions": [{"lang": "en-US", "value": "Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N)."}], "references": [{"url": "https://www.oracle.com/security-alerts/cpujan2026.html", "name": "Oracle Advisory", "tags": ["vendor-advisory"]}], "metrics": [{"cvssV3_1": {"attackVector": "NETWORK", "attackComplexity": "LOW", "privilegesRequired": "LOW", "userInteraction": "NONE", "scope": "UNCHANGED", "confidentialityImpact": "HIGH", "integrityImpact": "NONE", "availabilityImpact": "NONE", "version": "3.1", "vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N", "baseScore": 6.5, "baseSeverity": "MEDIUM"}}]}, "adp": [{"problemTypes": [{"descriptions": [{"type": "CWE", "lang": "en", "description": "CWE-noinfo Not enough information"}]}], "metrics": [{"other": {"type": "ssvc", "content": {"timestamp": "2026-01-21T18:54:17.078251Z", "id": "CVE-2026-21970", "options": [{"Exploitation": "none"}, {"Automatable": "no"}, {"Technical Impact": "partial"}], "role": "CISA Coordinator", "version": "2.0.3"}}}], "title": "CISA ADP Vulnrichment", "providerMetadata": {"orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0", "shortName": "CISA-ADP", "dateUpdated": "2026-01-21T18:59:51.402Z"}}]}}

{"dataType": "CVE_RECORD", "containers": {"adp": [{"title": "CISA ADP Vulnrichment", "metrics": [{"other": {"type": "ssvc", "content": {"id": "CVE-2026-21970", "role": "CISA Coordinator", "options": [{"Exploitation": "none"}, {"Automatable": "no"}, {"Technical Impact": "partial"}], "version": "2.0.3", "timestamp": "2026-01-21T18:54:17.078251Z"}}}], "problemTypes": [{"descriptions": [{"lang": "en", "type": "CWE", "description": "CWE-noinfo Not enough information"}]}], "providerMetadata": {"orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0", "shortName": "CISA-ADP", "dateUpdated": "2026-01-21T18:54:25.861Z"}}], "cna": {"metrics": [{"cvssV3_1": {"scope": "UNCHANGED", "version": "3.1", "baseScore": 6.5, "attackVector": "NETWORK", "baseSeverity": "MEDIUM", "vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N", "integrityImpact": "NONE", "userInteraction": "NONE", "attackComplexity": "LOW", "availabilityImpact": "NONE", "privilegesRequired": "LOW", "confidentialityImpact": "HIGH"}}], "affected": [{"vendor": "Oracle Corporation", "product": "Oracle Life Sciences Central Designer", "versions": [{"status": "affected", "version": "7.0.1.0", "versionType": "semver"}]}], "references": [{"url": "https://www.oracle.com/security-alerts/cpujan2026.html", "name": "Oracle Advisory", "tags": ["vendor-advisory"]}], "descriptions": [{"lang": "en-US", "value": "Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N)."}], "problemTypes": [{"descriptions": [{"lang": "en-US", "description": "Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data."}]}], "cpeApplicability": [{"nodes": [{"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:a:oracle:life_sciences_central_designer:7.0.1.0:*:*:*:*:*:*:*", "vulnerable": true}], "operator": "OR"}]}], "providerMetadata": {"orgId": "43595867-4340-4103-b7a2-9a5208d29a85", "shortName": "oracle", "dateUpdated": "2026-01-20T21:56:35.163Z"}}}, "cveMetadata": {"cveId": "CVE-2026-21970", "state": "PUBLISHED", "dateUpdated": "2026-01-21T18:59:51.402Z", "dateReserved": "2026-01-05T18:07:34.715Z", "assignerOrgId": "43595867-4340-4103-b7a2-9a5208d29a85", "datePublished": "2026-01-20T21:56:35.163Z", "assignerShortName": "oracle"}, "dataVersion": "5.2"}

{"affected": [{"affectedData": [{"product": "Oracle Life Sciences Central Designer", "vendor": "Oracle Corporation", "versions": [{"status": "affected", "version": "7.0.1.0", "versionType": "semver"}]}], "source": "secalert_us@oracle.com"}], "configurations": [{"nodes": [{"cpeMatch": [{"criteria": "cpe:2.3:a:oracle:life_sciences_central_designer:7.0.1.0:*:*:*:*:*:*:*", "matchCriteriaId": "FD42C36C-1BB2-4A80-B997-1F9C1861D7A0", "vulnerable": true}], "negate": false, "operator": "OR"}]}], "cveTags": [], "descriptions": [{"lang": "en", "value": "Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N)."}, {"lang": "es", "value": "Vulnerabilidad en el producto Oracle Life Sciences Central Designer de Oracle Health Sciences Applications (componente: Platform). La versi\u00f3n soportada que est\u00e1 afectada es 7.0.1.0. Vulnerabilidad f\u00e1cilmente explotable permite a un atacante con pocos privilegios con acceso a la red v\u00eda HTTP comprometer Oracle Life Sciences Central Designer. Ataques exitosos de esta vulnerabilidad pueden resultar en acceso no autorizado a datos cr\u00edticos o acceso completo a todos los datos accesibles de Oracle Life Sciences Central Designer. Puntuaci\u00f3n Base CVSS 3.1 6.5 (Impactos en la Confidencialidad). Vector CVSS: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N)."}], "id": "CVE-2026-21970", "lastModified": "2026-06-17T10:19:15.417", "metrics": {"cvssMetricV31": [{"cvssData": {"attackComplexity": "LOW", "attackVector": "NETWORK", "availabilityImpact": "NONE", "baseScore": 6.5, "baseSeverity": "MEDIUM", "confidentialityImpact": "HIGH", "integrityImpact": "NONE", "privilegesRequired": "LOW", "scope": "UNCHANGED", "userInteraction": "NONE", "vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N", "version": "3.1"}, "exploitabilityScore": 2.8, "impactScore": 3.6, "source": "secalert_us@oracle.com", "type": "Secondary"}], "ssvcV203": [{"source": "134c704f-9b21-4f2e-91b3-4a467353bcc0", "ssvcData": {"id": "CVE-2026-21970", "options": [{"exploitation": "none"}, {"automatable": "no"}, {"technicalImpact": "partial"}], "role": "CISA Coordinator", "timestamp": "2026-01-21T18:54:17.078251Z", "version": "2.0.3"}}]}, "published": "2026-01-20T22:16:00.090", "references": [{"source": "secalert_us@oracle.com", "tags": ["Vendor Advisory"], "url": "https://www.oracle.com/security-alerts/cpujan2026.html"}], "sourceIdentifier": "secalert_us@oracle.com", "vulnStatus": "Analyzed", "weaknesses": [{"description": [{"lang": "en", "value": "NVD-CWE-noinfo"}], "source": "nvd@nist.gov", "type": "Primary"}]}

{}

{"analysis": {"en": {"generated_at": "2026-04-18T04:26:25.445634+00:00", "value": {"mitigation_remediation": ["Apply the Oracle Security Patch for CVE\u20112026\u201121970 released in the CPU January 2026 advisory", "Restrict HTTP access to the Designer by enforcing network segmentation or VPN and inbound firewall rules", "Configure the application to run with the least\u2011privilege principle for all user accounts accessing the platform"], "summary": {"action": "Patch Now", "impact": "Remote unauthorized data access"}, "threat_synthesis": {"affected_systems": "Oracle Life Sciences Central Designer version 7.0.1.0 is affected. This is the specific release of the Oracle Health Sciences Applications Platform that contains the flaw.", "description_and_impact": "A remote exploitation flaw in Oracle Life Sciences Central Designer allows an attacker with limited privileges to access sensitive data over HTTP. The vulnerability effectively bypasses proper authorization controls, exposing confidential information to unauthenticated or low\u2011privileged users. It represents an improper authorization weakness, enabling attackers to read or potentially modify critical data within the application.", "risk_and_exploitability": "The issue carries a CVSS 3.1 base score of 6.5 and an EPSS of less than 1\u202f%. No public exploits have been indexed in the CISA KEV catalog. Successful exploitation requires only network access to the HTTP interface and does not need user interaction. Once accessed, an attacker can read all data that the application exposes without having to elevate privileges beyond the initial low\u2011privileged state."}}}}, "created": "2026-04-18T04:30:35.831907+00:00", "title": "Remote Unauthorized Data Access via Low Privilege HTTP Attack in Oracle Life Sciences Central Designer", "updated": "2026-04-18T04:30:35.831925+00:00", "vendors": [], "weaknesses": ["CWE-285"]}